Money
Briefing: A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?
Strategic angle: Explore the implications of a significant investment by a hedge fund in Immunovant and what it could mean for potential investors.
Editorial Staff 27 days ago